Market Overview: Nuclear alpha emitter therapy uses radioactive particles that emit alpha radiation to treat cancer. Alpha emitters such as actinium-225, bismuth-213, and radium-223 are attached to monoclonal antibodies that bind to cancer cells, delivering cell-killing radiation directly to the tumors. This innovative therapy reduces side effects and improves treatment outcomes for patients....
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian